Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Enanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals Inc (ENTA) Financials

ENTA Enanta Pharmaceuticals Inc

8.83

0.27 (3.15%)

28 Nov 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 30 September 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	8.218	5.826	19.425	10.261	-7.412	-17.082	-29.908	-31.949
Return on Equity (%)	8.562	6.197	20.696	10.835	-7.879	-18.478	-33.785	-49.739
Return on Invested Capital (%)	10.067	6.801	22.771	9.962	-10.598	-22.745	-42.725	-56.084
Operating Margin (%)	36.939	26.248	45.068	22.202	-28.593	-110.822	-141.815	-158.89
Net Profit Margin (%)	24.546	17.225	34.824	22.604	-29.531	-81.377	-141.313	-168.951
Book Value Per Share	14.18	15.778	20.298	23.473	22.692	19.737	15.508	10.294
Earnings Per Share	1.138	0.926	3.71	2.354	-1.801	-3.903	-5.876	-6.356
Cash Per Share	0.871	3.435	3.295	2.6	4.34	2.827	2.123	4.055
Working Capital Per Share	11.781	11.341	18.786	19.248	20.555	13.976	13.605	17.098
Operating Profit Per Share	4.637	5.377	10.654	10.415	6.1	4.797	4.158	3.762
EBIT Per Share	1.71	1.409	4.801	2.312	-1.744	-5.316	-5.897	-6.222
EBITDA Per Share	1.71	1.409	4.801	2.312	-1.744	-5.316	-5.897	-6.222
Free Cash Flow Per Share	1.3	0.946	3.734	2.464	-1.911	-4.031	-5.917	-6.038

Liquidity Ratios

Year End 30 September 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	19.04M	19.12M	19.4M	19.7M	20.08M	20.24M	N/A	N/A

Key Stats and Ratios

Year End 30 September 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	20.88M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-123.044	N/A	N/A	N/A	-169.905	N/A	N/A
Net Profit Margin (%)	N/A	-122.9	N/A	N/A	N/A	-185.564	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	181.37M
Price to Earnings Ratio	-1.4
Price to Sales Ratio	2.36
Price to Cash Ratio	2.19
Price to Book Ratio	0.86
Dividend Yield	-

Share Statistics

Shares Outstanding	21.19M
Average Volume (1 week)	405.25k
Average Volume (1 Month)	182.12k
52 Week Change	-10.08%
52 Week High	17.80
52 Week Low	8.00

More Ratios Coming Soon!

Enanta Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions